Curis (CRIS) Short-term Investments (2010 - 2024)
Curis' (CRIS) quarterly Short-term Investments came in at $18.4 million in Q2 2024, down 57.94% YoY from $43.7 million in Q3 2023, and up 70.61% on a QoQ basis from $10.8 million in Q1 2024.
Curis (CRIS) Short-term Investments (2010 - 2024) Analysis & Trends
Curis (CRIS) has 15 years of Short-term Investments data on file, last reported at $18.4 million in Q2 2024.
- Quarterly Short-term Investments fell 57.94% year-over-year to $18.4 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $18.4 million (down 57.94% YoY) and the FY2023 annual result came in at $29.7 million, down 55.05% from the prior year.
- Short-term Investments rose to $18.4 million in Q2 2024, from $10.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $102.2 million in Q1 2022 to a low of $153000.0 in Q1 2020.
- A 5-year average of $47.7 million and a median of $44.0 million in 2023 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2020 — Short-term Investments plunged 98.11% — and 2021, when it jumped 50582.35%.
- Tracing CRIS's Short-term Investments over 5 years: stood at $38.9 million in 2020, then soared by 95.12% to $75.9 million in 2021, then declined by 13.06% to $66.0 million in 2022, then plunged by 55.05% to $29.7 million in 2023, then sank by 38.07% to $18.4 million in 2024.
- The last three Short-term Investments figures came in at $18.4 million (Q2 2024), $10.8 million (Q1 2024), and $29.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 18.36 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 29.65 Mn |
| Sep 30, 2023 | 44.03 Mn |
| Jun 30, 2023 | 43.67 Mn |
| Mar 31, 2023 | 40.06 Mn |
| Dec 31, 2022 | 65.97 Mn |
| Sep 30, 2022 | 68.84 Mn |
| Jun 30, 2022 | 73.19 Mn |
| Mar 31, 2022 | 102.19 Mn |
| Dec 31, 2021 | 75.87 Mn |
| Sep 30, 2021 | 75.88 Mn |
| Jun 30, 2021 | 77.54 Mn |
| Mar 31, 2021 | 45.38 Mn |
| Dec 31, 2020 | 38.88 Mn |
| Jun 30, 2020 | 153,000.00 |
| Mar 31, 2020 | 153,000.00 |
| Dec 31, 2019 | 153,000.00 |
| Sep 30, 2019 | 153,000.00 |
| Jun 30, 2019 | 8.10 Mn |